Regulatory Background:
The "Pharmacovigilance Quality Management Guidelines" Article 55 marketing authorization holders to systematically perform signal detection across all collected adverse drug reaction information sources for timely identification of emerging drug safety risks.
Industry Status:
Signal detection is a vital pharmacovigilance activity, emphasized by regulations and guidelines. While professionals are exploring various detection methods, many remain uncertain about how to start, which techniques to use, whether IT tools are needed, and if approaches should differ by product.
Most domestic pharma companies either lack computerized signal detection systems or use generic modules that fail to address their specific needs, leading to inefficiency. As a result, manual detection remains a practical solution.
Given variations in regulations, company structures, and data sources, teams should prioritize developing tailored signal detection strategies for each product.
Exploration & Practice:
The SDM PV Team consists of multidisciplinary experts in clinical medicine, pharmacy, and statistics. Moving beyond generic approaches, we align with GVP guidelines while customizing signal detection strategies based on factors such as: product characteristics, launch year, registered countries, company capabilities, IT systems, PV resources, etc.
Our approach combines:
✔ Real-time monitoring (case reports, regulatory queries, complaints)
✔ Periodic reviews (regulatory safety updates, non-clinical/clinical data, aggregate reports)
We deliver product-specific, science-driven detection strategies with end-to-end implementation support. Contact us to optimize your pharmacovigilance signaling!
Signal strategy mind map presentation
This session focuses on Stakeholder Engagement: developing strategies for collaborative project decision-making and execution.
The updated draft guidance involves a focus on clinical trial design, regulatory considerations, and whether these trials can demonstrate that the drugs can maintain weight loss as determined by BMI.
Let's take a look back at the previous two installments of the Clinical Data Management “PM” series: Scope Management, which clarifies the scope of responsibilities of all parties involved in a clinical trial, and Project Resource Management, which focuses on the utilization of company and personal resources to accomplish data management tasks. In this installment, we will focus on the most important part of project management - project schedule management - to share the timeline planning and progress follow-up of data management activities, so as to efficiently complete the data management work under the premise of ensuring the data quality and reaching the important milestones of the project.
In the last session, we learned about project scope management for data management work, identifying the scope of responsibilities for data cleansing and data management activities. After defining the scope of the data management work, in this session, we will learn how to mobilize the resources within the scope of work to carry out the data management work more efficiently and with higher quality.
Shanghai SDM Vaccine Data Management Department, in collaboration with the International Project Department, has launched a series of training sessions on "Application of Project Management Knowledge in Data Management." The Application of Project Management Knowledge in Data Management Work contains eight modules, including Project Integration Management, Project Scope Management, Project Progress Management, Project Quality Management, Project Resource Management, Project Communication Management, Project Risk Management, and Project Stakeholder Management, etc. It mainly refers to the theoretical knowledge of the Guide to the Project Management Body of Knowledge (PMBOK Guide) and combines the content of the data management work and practical experience of the project.
Want to quickly penetrate the Chinese, American and European pharmaceutical markets? Registering for communication exchanges is the key!
SDM PV team detects drug safety risks.
SDM Vaccine Experts Share Roadmap to Avoid Clinical Trial Pitfalls.
this article outlines essential documentation preparation and strategic considerations for conducting pre-IND communication meetings with CDE, ensuring effective regulatory alignment and adequate guidance.
Clinical Database Design: Balancing Standardization and Innovation
Get in touch with SDM experts for your questions or comments and a member of our team will get back to you directly.
Let's Start a Conversation